Swiss National Bank
ACOR

Swiss National Bank’s Acorda Therapeutics ACOR Stock Holding History

Swiss National Bank’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-738
Closed -$254K – 2550
2019
Q3 		$254K Hold
738
– – ﹤0.01% 2476
2019
Q2 		$680K Buy
738
+160
+28% +$197K ﹤0.01% 2309
2019
Q1 		$921K Buy
578
+18
+3% +$32.4K ﹤0.01% 2107
2018
Q4 		$1.05M Buy
560
+17
+3% +$37K ﹤0.01% 1982
2018
Q3 		$1.28M Hold
543
– – ﹤0.01% 2003
2018
Q2 		$1.87M Sell
543
-145
-21% -$444K ﹤0.01% 1753
2018
Q1 		$1.95M Hold
688
– – ﹤0.01% 1648
2017
Q4 		$1.77M Buy
688
+53
+8% +$151K ﹤0.01% 1718
2017
Q3 		$1.8M Hold
635
– – ﹤0.01% 1687
2017
Q2 		$1.5M Hold
635
– – ﹤0.01% 1772
2017
Q1 		$1.6M Hold
635
– – ﹤0.01% 1715
2016
Q4 		$1.43M Hold
635
– – ﹤0.01% 1794
2016
Q3 		$1.59M Sell
635
-20
-3% -$59.7K ﹤0.01% 1661
2016
Q2 		$2M Buy
655
+32
+5% +$104K ﹤0.01% 1503
2016
Q1 		$1.91M Buy
623
+121
+24% +$502K ﹤0.01% 1478
2015
Q4 		$2.58M Hold
502
– – 0.01% 1163
2015
Q3 		$1.6M Buy
502
+61
+14% +$237K ﹤0.01% 1453
2015
Q2 		$1.76M Buy
441
+67
+18% +$259K ﹤0.01% 1398
2015
Q1 		$1.49M Buy
374
+6
+2% +$27.5K ﹤0.01% 1503
2014
Q4 		$1.81M Buy
368
+9
+3% +$38.6K 0.01% 1328
2014
Q3 		$1.46M Sell
359
-6
-2% -$22.5K 0.01% 1414
2014
Q2 		$1.48M Hold
365
– – 0.01% 1470
2014
Q1 		$1.66M Buy
365
+86
+31% +$348K 0.01% 1330
2013
Q4 		$978K Hold
279
– – ﹤0.01% 1520
2013
Q3 		$1.15M Sell
279
-14
-5% -$60.3K ﹤0.01% 1361
2013
Q2 		$1.16M Buy
+293
New +$1.21M 0.01% 1322

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Swiss National Bank's ACOR Position: Q4 2019 in Review

Swiss National Bank sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 738 shares — an estimated $254K sold.

Swiss National Bank first reported a position in ACOR in Q2 2013 and held it in 26 quarters. The position peaked at $2.58M in Q4 2015. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Swiss National Bank reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Swiss National Bank sold 738 Acorda Therapeutics shares in Q4 2019, an estimated $254K.
  • Swiss National Bank first reported a position in Acorda Therapeutics in Q2 2013 and held it in 26 quarters.
  • Swiss National Bank's Acorda Therapeutics position peaked at $2.58M in Q4 2015.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.